Moxacil

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Moxacil

What is Moxacil? (Identity and Classification)

Property Description
Active ingredient Amoxicillin
Pharmacological class Antibiotic (Penicillin class, Beta-lactam)
Origin Semi-synthetic
Available Forms Capsule, Tablet, Suspension, Dispersible Tablet
Primary Action Bactericidal (Kills bacteria)

What Type of Medication is Moxacil?

Moxacil is a widely utilized prescription-only medication whose active component is Amoxicillin, which chemically classifies it as an antibiotic. It belongs specifically to the penicillin class of drugs and is structurally defined as a beta-lactam antibiotic. Amoxicillin is recognized as a broad-spectrum agent for managing a wide range of bacterial infections.

Further categorization identifies Amoxicillin as an aminopenicillin, which is a semi-synthetic derivative chemically modified from the original penicillin structure to enhance its oral absorption. The drug is recognized globally for its efficacy and broad utility in medical practice and is included on lists of essential medicines.

Composition, Origin, and Available Forms of Amoxicillin

The medication is a single-ingredient product composed only of the active substance Amoxicillin combined with necessary pharmaceutical excipients. Moxacil is designed for oral administration and is distinguished by being available in several dosage forms to facilitate use across various patient groups, particularly pediatrics. These preparations typically include the standard capsule and tablet, as well as a liquid suspension and a dispersible tablet that can be mixed into liquid.

Primary Action: The Bactericidal Purpose

The fundamental function of Moxacil is its bactericidal action, meaning it actively kills bacteria. This effect is achieved through the inhibition of bacterial cell wall synthesis. Amoxicillin binds to and inactivates specific bacterial enzymes known as penicillin-binding proteins, which are critical for building and maintaining the bacterial cell wall's rigidity. This targeted action ensures the structural destruction of the microorganism, fulfilling the drug's essential role as an effective antimicrobial agent against susceptible pathogens.

Regulatory References

  1. Amoxicillin StatPearls Overview
  2. Amoxicillin on WHO Essential Medicines List

What side effects are possible with Moxacil?

Possible Side Effects and Safety Information

The safety profile of Moxacil (Amoxicillin) is defined by officially documented adverse reactions classified by frequency and the body systems they affect, according to government regulatory sources.

Frequency-Classified Adverse Reactions

Adverse effects are categorized based on their officially documented occurrence rates:

  • Common (may affect up to 1 in 10 people): Diarrhea, nausea, vomiting, and skin rash.
  • Uncommon (may affect up to 1 in 100 people): Urticaria (hives) and pruritus (itching).
  • Very Rare (may affect up to 1 in 10,000 people): Serious hypersensitivity reactions, blood and lymphatic system disorders, severe skin reactions, and hepatic disorders.

System-Organ-Class and Serious Reactions

Adverse events are grouped by the physiological system involved. The most frequently involved systems are Gastrointestinal Disorders and Skin and Subcutaneous Tissue Disorders.

Serious Adverse Reactions (SARs) officially listed in regulatory documents are rare but require attention. These include Anaphylaxis (a systemic allergic reaction), Severe Cutaneous Adverse Reactions (SCARs) such as Stevens-Johnson Syndrome (SJS), and Antibiotic-associated colitis (e.g., C. difficile colitis). Very rare events affecting the liver, such as Hepatitis and Cholestatic Jaundice, are also documented.


Population-Specific Safety Notes

The official safety profile includes specific considerations for certain patient groups:

  • Patients with Mononucleosis: Regulatory labeling advises against use due to an increased risk of developing a characteristic generalized skin rash.
  • Patients with Renal Impairment: The drug’s slower excretion rate in these individuals means that dosage adjustment may be necessary. Convulsions have been noted as a very rare risk in patients with impaired kidney function.

Time-Related Patterns and Safety Constraints

The profile notes that Hepatic events may appear during or shortly after treatment but are also documented to manifest several weeks after treatment cessation. The medicine is contraindicated in individuals with a history of severe hypersensitivity to Amoxicillin, any other penicillin, or another beta-lactam antibiotic.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define the Moxacil (Amoxicillin) overdose profile by specific clinical and physiological manifestations. Overdose is principally associated with gastrointestinal symptoms, including nausea, vomiting, and diarrhea, which may lead to disturbances of fluid and electrolyte balance. Severe manifestations include potential Central Nervous System (CNS) effects, specifically convulsions (seizures), which are more likely in patients with impaired renal function or those exposed to particularly high doses.

A key risk noted in prescribing information is Amoxicillin crystalluria (the presence of crystals in the urine), which can cause signs such as cloudy or bloody urine and decreased urination, and may progress to renal failure.

Required Emergency Actions

Regulatory authorities mandate that any suspected overdose requires immediate medical attention. You must contact your healthcare professional, hospital emergency department, or regional poison control centre immediately, even if the person appears asymptomatic. Treatment is symptomatic and supportive, and official procedures state that maintaining adequate fluid intake and diuresis is essential to mitigate the risk of crystalluria. Haemodialysis is a documented procedure that can be used to remove the drug from the circulation in cases of significant overdose, as no specific antidote is known.

Therapeutic Uses of Moxacil

Moxacil (Amoxicillin) is commonly applied across therapeutic domains involving bacterial infections, providing supportive relief when symptoms become more noticeable. It is relevant in contexts marked by increased discomfort and tension, helping to address symptom clusters that may become intense or disruptive.

The medication is commonly used to help with conditions characterized by periods of heightened symptoms, including acute otitis media, tonsillitis, community-acquired pneumonia, non-severe skin infections, and certain urinary tract infections. It is also applied in specialized clinical scenarios, such as infective prophylaxis and as a key component for eradicating H. pylori.

“The use is relevant for providing support that helps ease the overall symptom burden during acute symptomatic episodes.”

This assistance is generally used in settings where short-term symptomatic support is needed, contributing to improved comfort during periods of heightened symptoms.


Quick Fact: Relief for Acute Pain and Swelling
Moxacil is commonly applied in scenarios where localized pain, fever, and inflammation are driven by a susceptible bacterial pathogen, assisting with managing symptoms that may interfere with daily functioning.

Regulatory References

  1. US Food and Drug Administration (FDA) Labeling

Eligibility and Restrictions for Use

Eligibility Profile for Moxacil (Amoxicillin)

This section outlines the official eligibility and non-eligibility requirements for Moxacil (Amoxicillin) as documented in regulatory sources.


Absolute Contraindications

Moxacil is contraindicated and must not be used by individuals with a history of serious hypersensitivity (allergic) reactions to amoxicillin or any other penicillin-class drug. Use is also contraindicated in patients with a history of severe immediate hypersensitivity to any other beta-lactam antibiotic, such as certain cephalosporins.


Use Restrictions and Conditions

Population/Condition Regulatory Requirement
Infectious Mononucleosis Not recommended due to high risk of non-allergic rash.
Severe Renal Impairment Dose adjustment is mandatory; certain high-dose formulations are not recommended.
Pregnancy/Lactation Use in pregnancy is acceptable only if clearly needed (Category B). Use while breastfeeding requires caution due to excretion into human milk.
Infants (under 3 months) Requires a modified dose due to immature renal function.

The drug is generally approved for adults and most pediatric age groups who do not meet any of the exclusion criteria.

What should I know about interactions with other medicines?

Moxacil Interactions with other medicines and products

Moxacil, which contains the active ingredient Amoxicillin, has officially documented interaction patterns with other medicines and products, as detailed in regulatory prescribing information.

Documented Pharmacokinetic and Pharmacodynamic Interactions

Interacting Product Official Regulatory Description
Probenecid Co-administration leads to increased and prolonged blood levels of Moxacil due to inhibition of renal tubular secretion.
Oral Anticoagulants Reports of abnormal Prothrombin Time and increased INR; necessitates careful monitoring.
Allopurinol Concurrent use increases the incidence of skin rash.
Tetracyclines (and other bacteriostatic agents) May interfere with the bactericidal effect of Moxacil.
Combined Oral Contraceptives Potential for reduced efficacy due to documented effects on gut flora and estrogen reabsorption.

Official Constraints and Contextual Notes

There are no drug combinations formally classified as contraindicated due to interaction risk in the primary regulatory labels. However, a specific caution notes that Amoxicillin-class antibacterials should not be administered to patients with Infectious Mononucleosis, due to the high risk of a generalized rash. Additionally, Amoxicillin can cause false-positive results in certain non-enzymatic urine glucose tests, requiring the use of enzymatic methods for accurate measurement.

Mechanism of Action

Moxacil is a brand name for the drug amoxicillin, a beta-lactam antibiotic.

The biological target of amoxicillin is the bacterial cell wall synthesis machinery. Specifically, amoxicillin acts as a covalent inhibitor of bacterial transpeptidases, which are also known as penicillin-binding proteins (PBPs). These transpeptidases are essential enzymes responsible for the final cross-linking step of peptidoglycan strands, a critical polymer that provides structural integrity to the bacterial cell wall.

The molecular interaction involves the beta-lactam ring of amoxicillin binding irreversically to the active site of the PBP. This occurs because the beta-lactam ring structurally mimics the D-Ala-D-Ala terminus of the peptidoglycan precursor. This irreversible binding prevents the transpeptidation reaction.

The intracellular consequence of PBP inhibition is the suppression of the final stage of peptidoglycan assembly. As the cell continues to grow and divide, the structural integrity of the cell wall is compromised. This results in an imbalance between internal osmotic pressure and external constraints.

The downstream cascade involves the activation of bacterial autolytic enzymes (murein hydrolases), which further degrade the existing peptidoglycan. The system-level physiological consequence is bacteriolysis—the rupture of the bacterial cell membrane and wall, leading to bacterial death.

Amoxicillin + PBP xrightarrow Covalent Binding Amoxicillin-PBP (Inactive)

Dosage and Administration Information

How to Use Moxacil (Amoxicillin): Administration Guidelines

Moxacil is an oral and parenteral antibiotic administered according to specific frequency, dose, and duration protocols.


Administration and Dosing Protocols

The standard route of administration for capsules, tablets, and suspension is oral. Parenteral forms (Intravenous/Intramuscular) are used in settings where the oral route is not feasible.

Adult Dosing Regimen Frequency & Timing Key Administration Rule
Standard Dose: 500 mg or 250 mg Every 12 hours (q12h) or Every 8 hours (q8h) May be taken with or without food
Severe Dose: 875 mg or 500 mg Every 12 hours (q12h) or Every 8 hours (q8h) The 875 mg dose is contraindicated in severe renal impairment
H. pylori Eradication: 1 gram Twice or three times daily for 14 days Used in combination therapy with other agents

Duration and Special Populations

Treatment must be continued for a minimum of 48 to 72 hours after the patient is asymptomatic. For infections caused by Streptococcus pyogenes, a minimum of 10 days of treatment is recommended.

Pediatric Dosing is weight-based for children under 40 kg, typically ranging from 20 to 45 mg/kg/day in divided doses. The maximum dose for infants 3 months of age or younger is 30 mg/kg/day due to incompletely developed renal function.

Oral Suspension Preparation: The powder requires reconstitution by adding a specified amount of water and shaking vigorously; the mixture must be used within 14 days and should be measured using a calibrated device.

Missed Dose: If a dose is missed, it should be taken as soon as remembered. If it is nearly time for the next scheduled dose, the missed dose should be skipped; do not double the dose to make up for a forgotten one.

Recent Clinical Evidence

Research evidence / Overview of studies for Moxacil


Evidence for use in Ear, Nose, and Throat Infections

Research has examined Moxacil for conditions like middle ear infection (otitis media), tonsillitis, and sinusitis, which are often characterized by acute or disruptive episodes. Studies in this area typically compare how outcomes related to physical discomfort and systemic imbalance change over a defined time interval when patients were studied for Moxacil versus other treatments or a placebo.

The findings describe patterns observed in the studies, where Moxacil was studied for its use in addressing these conditions. Research highlights changes measured during the study period, which help contextualize how patients reported their experience and how symptoms evolved in the observed populations. However, evidence quality varies across studies, and some data may be limited by sample sizes that were modest.

Evidence for use in Lower Respiratory Tract Infections

Moxacil was also evaluated in studies focusing on infections of the lower airways, such as bacterial pneumonia and bronchitis. These studies explore short-term symptom changes and outcomes related to systemic or functional imbalance, often examining temporary physiological imbalance in conditions involving periods of heightened symptoms.

The data show patterns related to how patient-reported outcomes describing perceived discomfort evolved during the study period when individuals received Moxacil. These studies report how symptoms evolved in the observed populations, and research provides insight into short-term changes in these conditions associated with acute or disruptive episodes.

Evidence for use in Genitourinary Tract Infections and Skin Infections

Research has also described the use of Moxacil for conditions of the genitourinary tract, such as acute cystitis (bladder infection), and research describing its use in common bacterial infections of the skin and soft tissue. These studies often monitor outcomes reflecting daily functioning or activity level in conditions where symptoms may vary in intensity.

The studies explored how outcomes related to physical discomfort and localized inflammatory or irritative states evolved in the observed populations. Research highlights changes measured during the study period, which contributes to understanding symptom patterns and how patients reported their experience in these acute conditions. Data show patterns related to measured outcomes in some studies.

Long-term studies and follow-up

This section will synthesize what is currently known and what is not fully established regarding the long-term effects of Moxacil. Research has explored the potential for long-term health outcomes, but for a short-course drug like Moxacil, long-term effects are not fully established. Follow-up durations were limited in many initial studies, meaning there is limited information for long-term outcomes or the durability of the observed response.

Evidence in special populations

Research examined Moxacil use in specific groups, including children, older adults, and those who are pregnant or breastfeeding. Findings indicate that research examined Moxacil use in these groups, but the evidence quality varies across studies, and data for certain groups remain insufficient. For instance, in some populations, such as those with comorbid conditions or very young children, sample sizes were modest, and subgroup findings are uncertain. Research provides context, but it does not determine whether an individual will respond similarly. The need for continued research remains in order to further understand outcomes related to physiological strain or stress in these special patient populations.

What is still uncertain about Moxacil

This section synthesizes the main evidence gaps across all reviewed studies. The core uncertainties involve the consistency of findings, especially in light of growing bacterial resistance, and the comparative evidence is lacking against all available treatments. Additionally, there is limited information for long-term outcomes, as follow-up durations were limited in most trials. Findings describe group patterns, not personal outcomes, and this evidence highlights what is known—and what is still uncertain—in the broader evidence landscape. Research is ongoing to address these gaps and further understand all outcomes linked to inflammatory or irritative states.

Frequently Asked Questions (FAQ)

Common questions about Moxacil (FAQ)


Q: How quickly should I expect to feel better after starting Moxacil?

Official guidelines indicate that Moxacil treatment should be continued for a minimum of 48 to 72 hours after the patient becomes asymptomatic or the bacteria have been eliminated. This time frame provides context for when symptom improvement might be expected, though individual response to treatment varies.


Q: Does Moxacil interfere with birth control pills?

Official labeling includes a warning that Moxacil, which contains amoxicillin, may potentially reduce the effectiveness of combined oral contraceptives (birth control pills). Due to this potential interaction, it is important for individuals to discuss necessary precautions with a healthcare provider.


Q: Is it okay to drink alcohol in moderation while taking Moxacil?

Official regulatory documents do not list a specific formal interaction or contraindication between alcohol and Moxacil. Therefore, no formal restriction on alcohol consumption is stated in the medicine's labeling.


Q: Can Moxacil be used to treat a viral infection?

Moxacil is an antibacterial drug belonging to the penicillin class. Its mechanism of action is to kill bacteria. The drug is indicated for use in infections that are proven or strongly suspected to be caused by bacteria, as it is not effective against viruses.


Q: How long does Moxacil stay in your system after the last dose?

Official pharmacological data indicates that the half-life of amoxicillin is approximately 61.3 minutes. Detectable serum levels are observed up to eight hours after an orally administered dose.


Q: Is Moxacil safe for older adults?

Moxacil is generally used in older adults. However, because the drug is removed from the body primarily through the kidneys, dosage adjustment is mandatory for patients with severe renal impairment, a condition more prevalent in older adults.


Q: Does Moxacil affect kidney function?

Moxacil is mainly excreted by the kidneys, and doses must be adjusted for individuals with existing kidney impairment. Official warnings also note that in patients with poor kidney function, there is a very rare risk of convulsions (seizures). Any concerns regarding kidney function should be discussed with a healthcare provider.


Q: Is it true that antibiotics like Moxacil can sometimes cause a yeast infection?

While not listed as a common effect, reports indicate that amoxicillin products have been associated with vaginal candidiasis (yeast infection) and other types of mucocutaneous candidiasis. This is a possibility because antibiotics can disrupt the body's natural balance of microorganisms.


Q: Is Moxacil a broad-spectrum antibiotic?

Yes, Moxacil is classified as a broad-spectrum antibiotic in the aminopenicillin class. This classification means it is designed to be effective against a wide variety of susceptible Gram-positive and Gram-negative bacteria.


Q: Can Moxacil interact with supplements or vitamins?

Regulatory documents list specific interactions with certain prescription drugs. However, they do not formally mention interactions with general supplements or vitamins. Individuals should inform their healthcare provider about all products, including supplements and vitamins, they are currently using.


Q: Is Moxacil safe to use during pregnancy?

Moxacil is classified as Pregnancy Category B. Official labeling states that use in pregnancy is acceptable only if clearly needed, and the benefits are determined to outweigh the potential risks. There is limited comprehensive data on its use in pregnant women.


Q: Does Moxacil have an impact on the gut flora (good bacteria)?

Yes, official labeling acknowledges that Moxacil affects the normal bacteria in the gut. This disruption is a factor in the potential reduced efficacy of oral contraceptives in some cases, and it is also noted as a risk factor for developing C. difficile-associated diarrhea.


Q: What's the risk of getting a Clostridium difficile (C. diff) infection from Moxacil?

Official labeling warns that Clostridioides difficile-associated diarrhea (CDAD) is a serious adverse reaction reported with the use of amoxicillin. This infection can range from mild to life-threatening. The labeling advises that if significant or persistent diarrhea occurs, a medical professional should be consulted immediately.


Q: Is Moxacil considered a strong antibiotic?

Moxacil is classified as a broad-spectrum antibiotic, indicating it is active against many types of bacteria. Its inclusion on the World Health Organization's List of Essential Medicines confirms it is a proven and widely utilized drug for managing common bacterial infections.


Q: Can Moxacil cause stomach upset or diarrhea?

Diarrhea, nausea, and vomiting are listed among the most common side effects reported in clinical trials for Moxacil (amoxicillin). Any persistent or severe digestive upset should be reported to a healthcare provider.


Q: Is it normal to feel tired or drowsy while taking Moxacil?

While fatigue or drowsiness are not primary common side effects, official labeling does list nervous system effects such as dizziness and, less commonly, confusion or behavioral changes. Extreme weakness has also been reported in rare, specific adverse reactions.


Q: Are there any foods I should avoid while on Moxacil?

There are no specific food avoidance instructions for Moxacil. According to official administration guidelines, the medicine can be taken with or without food.


Q: How is Moxacil different from Augmentin?

Moxacil is a single-ingredient drug containing only the antibiotic amoxicillin. Augmentin is a combination product that contains amoxicillin plus clavulanate (clavulanic acid). The added clavulanate acid helps protect the amoxicillin from being broken down by certain types of resistant bacteria.


Q: What is the active ingredient in Moxacil?

The active ingredient in Moxacil is Amoxicillin. It is classified as a semi-synthetic antibiotic belonging to the penicillin class.


Q: Does Moxacil cause sensitivity to the sun?

Official regulatory documents list various severe skin reactions but do not list photosensitivity (sun sensitivity) as a reported common, uncommon, or rare side effect for amoxicillin.


Q: Is Moxacil effective for strep throat?

Yes, Moxacil is indicated for the treatment of upper respiratory tract infections, including those caused by susceptible Streptococcus species. A minimum of 10 days of treatment is recommended for infections caused by Streptococcus pyogenes (the cause of most strep throat cases).


Q: Can a person develop resistance to Moxacil over time?

Official labeling includes a warning about the Development of Drug-Resistant Bacteria. To reduce the development of drug-resistant bacteria, the product labeling indicates that the drug should be reserved for use in infections proven or strongly suspected to be caused by susceptible bacteria.


Q: Can Moxacil cause headaches?

Headaches have been reported as an adverse event in some post-marketing data and clinical trials for amoxicillin-class products, although they are not listed as one of the most common side effects.


Q: Why do some people experience nausea with Moxacil?

Nausea and vomiting are listed among the most common adverse reactions observed during clinical trials. Although the exact underlying cause for an individual patient is not specified in the labeling, these effects are a common physiological response to many oral antibiotics.


Q: Is Moxacil prescribed for skin infections?

Yes, Moxacil is officially indicated for the treatment of infections of the Skin and Skin Structure that are known to be caused by susceptible bacteria.


Q: Is Moxacil commonly used for ear infections in kids?

Yes, Moxacil is indicated and commonly used for the treatment of upper respiratory tract infections, such as otitis media (middle ear infection), in both adults and pediatric patients over three months of age.


Q: Are there generic versions of Moxacil available?

Yes, the active ingredient in Moxacil, amoxicillin, is an established drug and is widely available from various manufacturers as a therapeutically equivalent generic product.


Q: Does Moxacil affect the results of any blood tests?

Moxacil can cause false-positive results in certain non-enzymatic urine glucose tests. It has also been reported to affect blood clotting test results (Prothrombin Time/INR) in people taking oral anticoagulants (blood thinners).


Q: Can Moxacil affect my ability to drive or operate machinery?

Because adverse reactions like dizziness and confusion have been reported with Moxacil, caution is advised before driving or operating machinery.


Q: Why do doctors recommend taking Moxacil at evenly spaced times?

Moxacil has a short half-life and is prescribed in divided doses (e.g., every 8 or 12 hours). Taking it at regularly spaced times helps to maintain consistent and adequate levels of the antibiotic in the bloodstream to effectively eliminate the infection.


Q: Is it normal to have a metallic taste in my mouth with Moxacil?

While not a common side effect, official product information has reported disturbances in taste, known as dysgeusia, with the use of amoxicillin-class products.


Q: Are there any long-term side effects associated with Moxacil?

For this short-course drug, most side effects resolve after stopping treatment. However, very rare but serious reactions, such as hepatic events (liver issues), have been documented to appear several weeks after treatment cessation. Follow-up studies for long-term outcomes are limited.


Q: Can Moxacil be crushed or opened if I have trouble swallowing pills?

Moxacil is available in alternative forms, including a liquid suspension and chewable/dispersible tablets, which are designed for patients who have difficulty swallowing pills. There are no official instructions recommending that standard tablets or capsules be crushed.


Q: What should I do if I vomit shortly after taking Moxacil?

Official labeling advises against doubling the dose to compensate. If vomiting occurs, particularly if severe, a healthcare professional should be contacted, as severe vomiting can, in rare cases, be associated with a serious drug-related condition.


Q: Does Moxacil have a strong taste?

The oral liquid suspension and chewable tablets of Amoxicillin often contain flavorings (such as fruit or bubble-gum) to improve palatability for patients, giving them a notable taste.

How should Moxacil be stored and disposed of?

How to Store and Dispose of Moxacil (Amoxicillin)

Official regulatory labeling dictates specific conditions for storing and disposing of Moxacil to maintain its efficacy and ensure safety.

Storage and Handling Requirements

Item Requirement
Solid Forms (Capsules/Powder) Store at controlled room temperature (15 C to 30 C), protecting from moisture and excessive heat.
Reconstituted Suspension May be stored in a refrigerator; Do not freeze.
Stability Reconstituted liquid suspension must be discarded after 14 days, even if refrigerated.
Packaging Keep in the original, tightly closed container and store out of the reach and sight of children.

Disposal Instructions

Unused or expired Moxacil should be disposed of via an authorized drug take-back program or collection kiosk. If these options are unavailable, mix the medicine with an unappealing substance (like dirt or coffee grounds) in a sealed bag before placing it in the household trash. Do not flush the medication down the toilet or pour it down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Moxacil found in:

A-Z Index: